Skip to content

Our publications

Since its inception, Inovarion has contributed to the completion of high-level research projects. Our scientists have actively participated to studies resulting in publications in prestigious, high-impact journals. These publications span a wide range of fields within biology, driving innovation and fostering progress across numerous therapeutic and scientific domains.

See all on Pubmed
Filter :
Cancer Research
Oncology

Allosteric inhibition of HER2 by Moesin-mimicking compounds targets HER2-positive cancers and brain metastases

Learn more
JID innovations
Metabolic diseases

Deletion of TNFAIP6 Gene in Human Keratinocytes Demonstrates a Role for TSG-6 to Retain Hyaluronan Inside Epidermis

Learn more
PNAS
Metabolic diseases

Arrest of WNT/β-catenin signaling enables the transition from pluripotent to differentiated germ cells in mouse ovaries

Learn more
Cancers (Basel)
Oncology

Mitochondrial Metabolism in Carcinogenesis and Cancer Therapy

Learn more
Cardiovascular research
Metabolic diseases

Different cardiovascular and pulmonary phenotypes for single- and double-knock-out mice deficient in BMP9 and BMP10

Learn more
Blood.
Oncology

GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness

Learn more
JCI Insight
Molecular Biology

Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth

Learn more
Cells
Oncology

Microtubule-Associated Protein ATIP3, an Emerging Target for Personalized Medicine in Breast Cancer

Learn more
Oncoimmunology
Oncology

Tumor spread or siege immunity: dissemination to distant metastasis or not

Learn more
Science Advances
Immunology

Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution

Learn more
Analytica Chimica Acta
Metabolic diseases

DietSee: An on-hand, portable, strip-type biosensor for lipolysis monitoring via real-time amperometric determination of glycerol in blood

Learn more
Science Translational Medicine
Immunology

Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopenia

Learn more